結果ページ11 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (1012)
- オーストラリア (58)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (94)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (738)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (14)
- ポーランド (9)
- ロシア (2)
- 韓国 (12)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (69)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
バイオテクノロジー (2611)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S NVON.MX | $1,424.1 84.32 USD |
+2.11
|
$3.28T 194.46B USD | $1.45K 85.68 USD | $1,410 83.49 USD | $1,442.17 85.39 USD | $3.28T 194.46B USD | 22.93 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,784 520.12 USD |
0
|
$2.26T 133.57B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.26T 133.57B USD | 0 | -$72.9 -4.3 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $627.69 127.22 USD |
+0.49
|
$649.57B 131.66B USD | $1 0.2 USD | $627.69 127.22 USD | $627.69 127.22 USD | $649.57B 131.66B USD | 0 | -$5.31 -1.07 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $393.1 429.71 USD |
+0.91
|
$101.93B 111.43B USD | $8 8.75 USD | $393.1 429.71 USD | $396 432.88 USD | $101.93B 111.43B USD | 0 | -$3.31 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $393.35 429.98 USD |
+1.07
|
$101.01B 110.42B USD | $22 24.05 USD | $387.85 423.97 USD | $390.25 426.6 USD | $101.01B 110.42B USD | 0 | -$3.34 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $387.7 423.81 USD |
-0.73
|
$100.28B 109.62B USD | $5 5.47 USD | $387.7 423.81 USD | $387.7 423.81 USD | $100.28B 109.62B USD | 0 | -$3.36 -3.6 USD | |
| CSL CMXHF | $151.5 — |
-4.36
|
$76.25B — | $54 — | $151.5 — | $151.5 — | $76.25B — | 27.79 | $5.45 — | |
| CSL Limited CSJ.F | $136.4 149.1 USD |
-0.54
|
$66.22B 72.39B USD | $50 54.66 USD | $136.2 148.89 USD | $136.4 149.1 USD | $66.22B 72.39B USD | 28.47 | $4.79 5.24 USD | |
| CSL Limited CSJA.F | $67 73.24 USD |
-1.47
|
$65.6B 71.71B USD | $5 5.47 USD | $67 73.24 USD | $67 73.24 USD | $65.6B 71.71B USD | 27.80 | $2.41 2.63 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $46.01 9.33 USD |
+1.77
|
$302.81B 61.37B USD | $2.46K 498.6 USD | $45.65 9.25 USD | $46.75 9.48 USD | $302.81B 61.37B USD | 12.78 | $3.6 0.73 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $9,488 561.81 USD |
+0.03
|
$1.02T 60.42B USD | $212 12.55 USD | $9,484 561.57 USD | $9,484 561.57 USD | $1.02T 60.42B USD | 12.59 | $753.11 44.59 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,019,000 769.18 USD |
-1.45
|
$72.53T 54.75B USD | $90.87K 68.59 USD | $1,015,000 766.16 USD | $1,040,000 785.03 USD | $72.53T 54.75B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $438.1 478.9 USD |
+2.55
|
$46.5B 50.83B USD | $51 55.75 USD | $424.5 464.04 USD | $429.2 469.17 USD | $46.5B 50.83B USD | 12.72 | $34.43 37.64 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $86.26 17.48 USD |
0
|
$224.95B 45.59B USD | $0 0 USD | $86.26 17.48 USD | $86.26 17.48 USD | $224.95B 45.59B USD | 0 | -$0.59 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $131.95 26.74 USD |
0
|
$201.7B 40.88B USD | $0 0 USD | $131.95 26.74 USD | $131.95 26.74 USD | $201.7B 40.88B USD | 35.95 | $3.67 0.74 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $264.1 288.7 USD |
-0.3
|
$34.44B 37.64B USD | $30 32.79 USD | $264.1 288.7 USD | $267.8 292.74 USD | $34.44B 37.64B USD | 0 | -$1.83 -2.0004 USD | |
| argenx SE ARGNF | $562 — |
0
|
$35.62B — | $10 — | $562 — | $562 — | $35.62B — | 34.24 | $16.41 — | |
| UCB SA UCBJF | $179.39 — |
0
|
$35.31B — | $84 — | $179.39 — | $179.39 — | $35.31B — | 28.65 | $6.26 — | |
| argenx SE 1AE.F | $507.8 555.09 USD |
+1.16
|
$31.55B 34.49B USD | $10 10.93 USD | $507.8 555.09 USD | $507.8 555.09 USD | $31.55B 34.49B USD | 35.86 | $14.16 15.48 USD | |
| argenx SE 1AEA.F | $500 546.57 USD |
+0.81
|
$31.44B 34.37B USD | $9 9.84 USD | $500 546.57 USD | $500 546.57 USD | $31.44B 34.37B USD | 35.23 | $14.19 15.51 USD | |
| argenx SE ARGX.VI | $512.6 560.34 USD |
+2.48
|
$31.3B 34.21B USD | $0 0 USD | $509.2 556.62 USD | $512.6 560.34 USD | $31.3B 34.21B USD | 35.72 | $14.35 15.69 USD | |
| UCB SA UNC.F | $162.7 177.85 USD |
+1.02
|
$31.24B 34.15B USD | $1 1.09 USD | $162.7 177.85 USD | $162.7 177.85 USD | $31.24B 34.15B USD | 29.96 | $5.43 5.94 USD | |
| UCB SA UNC0.F | $80 87.45 USD |
+0.63
|
$31.11B 34.01B USD | $50 54.66 USD | $80 87.45 USD | $80 87.45 USD | $31.11B 34.01B USD | 29.30 | $2.73 2.98 USD | |
| UCB SA UCB.VI | $163.4 178.62 USD |
+1.68
|
$31.05B 33.94B USD | $0 0 USD | $161.9 176.98 USD | $164.35 179.66 USD | $31.05B 33.94B USD | 29.87 | $5.47 5.98 USD | |
| BioNTech SE B1NT34.SA | $38.29 7.76 USD |
-0.39
|
$147.27B 29.85B USD | $0 0 USD | $38.44 7.79 USD | $38.44 7.79 USD | $147.27B 29.85B USD | 0 | -$1.28 -0.2 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $224 244.86 USD |
+0.9
|
$25.96B 28.38B USD | $25 27.33 USD | $222 242.68 USD | $222 242.68 USD | $25.96B 28.38B USD | 0 | -$3.15 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
+0.58
|
$25.88B 28.29B USD | $509 556.41 USD | $16.6 18.15 USD | $16.6 18.15 USD | $25.88B 28.29B USD | 0 | -$0.24 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $163,100 123.11 USD |
+1.62
|
$35.51T 26.8B USD | $529.38K 399.6 USD | $160,200 120.92 USD | $163,400 123.34 USD | $35.51T 26.8B USD | 0 | $0 0 USD | |
| BioNTech SE 22UA.F | $97.25 106.31 USD |
+0.46
|
$23.38B 25.56B USD | $2.09K 2.29K USD | $95.95 104.89 USD | $97.35 106.42 USD | $23.38B 25.56B USD | 0 | -$3.18 -3.4 USD | |
| BioNTech SE BNTX.VI | $96.3 105.27 USD |
-0.98
|
$23.15B 25.31B USD | $428 467.86 USD | $96.3 105.27 USD | $97.65 106.74 USD | $23.15B 25.31B USD | 0 | -$3.19 -3.4 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $29.33 32.06 USD |
+1.07
|
$16.76B 18.32B USD | $15 16.4 USD | $29.33 32.06 USD | $29.33 32.06 USD | $16.76B 18.32B USD | 13.83 | $2.12 2.32 USD | |
| Royalty Pharma plc RPD.MU | $29.31 32.04 USD |
+0.83
|
$16.72B 18.28B USD | $0 0 USD | $29.31 32.04 USD | $29.31 32.04 USD | $16.72B 18.28B USD | 13.82 | $2.12 2.32 USD | |
| Incyte Corporation I1NC34.SA | $192.28 38.97 USD |
+12.27
|
$83.51B 16.93B USD | $401 81.28 USD | $192.28 38.97 USD | $192.77 39.07 USD | $83.51B 16.93B USD | 384.56 | $0.5 0.1 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.48 | $51.95 3.08 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Innovent Biologics IVBXF | $9.26 — |
-2.53
|
$15.27B — | $166.83K — | $9.26 — | $9.6 — | $15.27B — | 0 | -$0.01 — | |
| Incyte Corporation INCY.MX | $1,180.69 69.91 USD |
0
|
$255.01B 15.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $255.01B 15.1B USD | 312.35 | $3.78 0.22 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.05 8.8 USD |
+1.9
|
$13.59B 14.85B USD | $5.07K 5.54K USD | $8 8.75 USD | $8.05 8.8 USD | $13.59B 14.85B USD | 0 | -$0.01 -0.01 USD | |
| United Therapeutics Corporation UTH.F | $278.5 304.44 USD |
-1.1
|
$12.69B 13.87B USD | $15 16.4 USD | $278.5 304.44 USD | $278.5 304.44 USD | $12.69B 13.87B USD | 12.56 | $22.16 24.22 USD | |
| Genmab A/S GNMSF | $218.13 — |
0
|
$13.67B — | $6 — | $218.13 — | $218.13 — | $13.67B — | 12.80 | $17.04 — | |
| Genmab A/S GMAB.VI | $194.25 212.34 USD |
+0.94
|
$11.96B 13.08B USD | $0 0 USD | $192.9 210.87 USD | $195.15 213.33 USD | $11.96B 13.08B USD | 13.01 | $14.92 16.31 USD | |
| WuXi Biologics (Cayman) WXIBF | $3.2 — |
0
|
$13.02B — | $400 — | $3.2 — | $3.2 — | $13.02B — | 29.09 | $0.11 — | |
| Insmed Incorporated IM8N.SG | $63 68.87 USD |
-0.79
|
$11.62B 12.7B USD | $0 0 USD | $63 68.87 USD | $63 68.87 USD | $11.62B 12.7B USD | 0 | -$5.22 -5.7 USD | |
| Incyte Corporation ICY.F | $58.52 63.97 USD |
-0.54
|
$11.56B 12.64B USD | $17 18.58 USD | $58.52 63.97 USD | $58.52 63.97 USD | $11.56B 12.64B USD | 325.11 | $0.18 0.2 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Insmed Incorporated IM8N.F | $63 68.87 USD |
-5.97
|
$11.47B 12.54B USD | $130 142.11 USD | $63 68.87 USD | $63 68.87 USD | $11.47B 12.54B USD | 0 | -$5.51 -6.02 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Moderna, Inc. MRNA.MX | $521.93 30.9 USD |
+2.44
|
$208.4B 12.34B USD | $300 17.76 USD | $521.9 30.9 USD | $525.1 31.09 USD | $208.4B 12.34B USD | 0 | -$163.2 -9.6 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $158.1 32.04 USD |
-3.6
|
$60.64B 12.29B USD | $700 141.88 USD | $158.1 32.04 USD | $159.3 32.29 USD | $60.64B 12.29B USD | 20.21 | $7.82 1.58 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.4 5.9 USD |
0
|
$11.16B 12.2B USD | $208 227.37 USD | $5.4 5.9 USD | $5.4 5.9 USD | $11.16B 12.2B USD | 28.42 | $0.19 0.21 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.7 2.95 USD |
-2.17
|
$10.99B 12.01B USD | $840 918.23 USD | $2.7 2.95 USD | $2.7 2.95 USD | $10.99B 12.01B USD | 27.01 | $0.1 0.11 USD | |
| Ascendis Pharma A/S A1SN34.SA | $65.49 13.27 USD |
0
|
$58.5B 11.86B USD | $0 0 USD | $65.49 13.27 USD | $65.49 13.27 USD | $58.5B 11.86B USD | 0 | -$37.17 -7.5 USD | |
| Exelixis, Inc. EX9.F | $36.78 40.21 USD |
+0.44
|
$10.29B 11.25B USD | $230 251.42 USD | $36.78 40.21 USD | $36.78 40.21 USD | $10.29B 11.25B USD | 19.35 | $1.9 2.08 USD | |
| Verona Pharma plc I9SA.F | $74.2 81.11 USD |
+3.34
|
$10.14B 11.08B USD | $260 284.22 USD | $72.8 79.58 USD | $74.2 81.11 USD | $10.14B 11.08B USD | 0 | -$1.69 -1.8 USD | |
| Moderna, Inc. 0QF.F | $24 26.24 USD |
+5.29
|
$9.76B 10.67B USD | $1.28K 1.4K USD | $22.63 24.73 USD | $24 26.24 USD | $9.76B 10.67B USD | 0 | -$7.24 -7.9 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $49.76 54.39 USD |
+1.36
|
$9.54B 10.43B USD | $0 0 USD | $48.51 53.03 USD | $48.69 53.22 USD | $9.54B 10.43B USD | 21.08 | $2.36 2.58 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.55 — |
0
|
$10.38B — | $1.26K — | $0.55 — | $0.55 — | $10.38B — | 55.29 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $9.48 — |
0
|
$10.38B — | $321 — | $9.48 — | $9.48 — | $10.38B — | 32.68 | $0.29 — | |
| Moderna, Inc. 0QF.MU | $23.76 25.97 USD |
+2.04
|
$9.46B 10.34B USD | $35 38.26 USD | $23.05 25.19 USD | $23.76 25.97 USD | $9.46B 10.34B USD | 0 | -$7.47 -8.1 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.17 52.66 USD |
-1.53
|
$9.34B 10.21B USD | $50 54.66 USD | $48.17 52.66 USD | $48.17 52.66 USD | $9.34B 10.21B USD | 20.15 | $2.39 2.61 USD | |
| Ascendis Pharma A/S A71.F | $154 168.34 USD |
+1.99
|
$9.32B 10.19B USD | $60 65.59 USD | $154 168.34 USD | $154 168.34 USD | $9.32B 10.19B USD | 0 | -$5.69 -6.2 USD | |
| Moderna, Inc. MRNA.VI | $23.85 26.07 USD |
+1.36
|
$9.27B 10.14B USD | $694 758.64 USD | $22.97 25.1 USD | $23.09 25.24 USD | $9.27B 10.14B USD | 0 | -$7.64 -8.3 USD | |
| Akeso, Inc. 4RY.F | $9.05 9.89 USD |
0
|
$8.22B 8.98B USD | $172 188.02 USD | $9.05 9.89 USD | $9.15 10 USD | $8.22B 8.98B USD | 0 | -$0.07 -0.07 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.39 1.9 USD |
0
|
$44.16B 8.95B USD | $0 0 USD | $9.39 1.9 USD | $9.39 1.9 USD | $44.16B 8.95B USD | 62.60 | $0.15 0.03 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Bio-Techne Corporation TECH.MX | $926.1 54.84 USD |
-36.96
|
$147.15B 8.71B USD | $0 0 USD | $0 0 USD | $0 0 USD | $147.15B 8.71B USD | 36.46 | $25.4 1.5 USD | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Blueprint Medicines Corporation 2L9.F | $112 122.43 USD |
+0.45
|
$7.25B 7.93B USD | $50 54.66 USD | $111.4 121.78 USD | $112 122.43 USD | $7.25B 7.93B USD | 0 | -$2.19 -2.3 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,018.51 60.31 USD |
0
|
$128.06B 7.58B USD | $300 17.76 USD | $1,018.51 60.31 USD | $1,018.51 60.31 USD | $128.06B 7.58B USD | 14.14 | $72.01 4.26 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Bio-Techne Corporation TE1.F | $42.4 46.35 USD |
+1.44
|
$6.76B 7.39B USD | $50 54.66 USD | $41.8 45.69 USD | $42.4 46.35 USD | $6.76B 7.39B USD | 59.71 | $0.71 0.78 USD | |
| Roivant Sciences Ltd. 87S.F | $9.66 10.56 USD |
+0.67
|
$6.71B 7.34B USD | $600 655.88 USD | $9.66 10.56 USD | $9.72 10.62 USD | $6.71B 7.34B USD | 0 | -$0.65 -0.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $34.8 38.04 USD |
-0.57
|
$6.64B 7.26B USD | $86 94.01 USD | $34.8 38.04 USD | $34.8 38.04 USD | $6.64B 7.26B USD | 0 | -$3.52 -3.8 USD | |
| Corcept Therapeutics Incorporated HTD.F | $61 66.68 USD |
+1.19
|
$6.52B 7.13B USD | $115 125.71 USD | $59.88 65.46 USD | $61 66.68 USD | $6.52B 7.13B USD | 61.61 | $0.99 1.08 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $33.34 36.45 USD |
+1.12
|
$6.47B 7.08B USD | $100 109.31 USD | $33.34 36.45 USD | $33.34 36.45 USD | $6.47B 7.08B USD | 0 | -$3.07 -3.3 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.6 20.33 USD |
-0.8
|
$6.44B 7.04B USD | $50 54.66 USD | $18.6 20.33 USD | $18.6 20.33 USD | $6.44B 7.04B USD | 0 | -$4.44 -4.8 USD | |
| Legend Biotech Corporation 9LB.F | $30.6 33.45 USD |
+12.5
|
$6.33B 6.92B USD | $130 142.11 USD | $27.4 29.95 USD | $30.6 33.45 USD | $6.33B 6.92B USD | 0 | -$0.92 -1.005 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $97.5 106.58 USD |
+2.78
|
$6.15B 6.72B USD | $20 21.86 USD | $94.22 103 USD | $97.5 106.58 USD | $6.15B 6.72B USD | 15.59 | $6.25 6.83 USD | |
| TG Therapeutics, Inc. NKB2.F | $34.18 37.36 USD |
+6.63
|
$5.92B 6.47B USD | $45 49.19 USD | $34.18 37.36 USD | $34.18 37.36 USD | $5.92B 6.47B USD | 162.73 | $0.21 0.23 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$107.6B 6.37B USD | $0 0 USD | $0 0 USD | $0 0 USD | $107.6B 6.37B USD | 0 | -$57.25 -3.3 USD | |
| Financière de Tubize SA FTD.F | $128 139.92 USD |
+1.27
|
$5.82B 6.37B USD | $70 76.52 USD | $128 139.92 USD | $128 139.92 USD | $5.82B 6.37B USD | 64.00 | $2 2.19 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.74 51.09 USD |
-0.47
|
$5.81B 6.35B USD | $9 9.84 USD | $46.74 51.09 USD | $46.74 51.09 USD | $5.81B 6.35B USD | 14.16 | $3.3 3.61 USD | |
| Financière de Tubize SA FTD.SG | $128.2 140.14 USD |
+0.47
|
$5.78B 6.32B USD | $0 0 USD | $128 139.92 USD | $128.2 140.14 USD | $5.78B 6.32B USD | 63.46 | $2.02 2.21 USD | |
| ALK-Abelló A/S AKBLF | $26.99 — |
0
|
$6.31B — | $2 — | $26.99 — | $27.05 — | $6.31B — | 42.17 | $0.64 — | |
| ALK-Abelló A/S 4AJ0.F | $24.7 27 USD |
+0.32
|
$5.53B 6.04B USD | $11 12.02 USD | $24.34 26.61 USD | $24.7 27 USD | $5.53B 6.04B USD | 44.10 | $0.56 0.61 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $243.6 266.29 USD |
+2.01
|
$5.5B 6.01B USD | $50 54.66 USD | $239.1 261.37 USD | $245.5 268.36 USD | $5.5B 6.01B USD | 0 | -$15.25 -16.6 USD | |
| 3SBio Inc. 83B.F | $2.22 2.43 USD |
+3.74
|
$5.49B 6B USD | $150 163.97 USD | $2.16 2.36 USD | $2.22 2.43 USD | $5.49B 6B USD | 22.19 | $0.1 0.11 USD | |
| Telix Pharmaceuticals TLPPF | $16.6 — |
-3.26
|
$5.57B — | $200 — | $16.6 — | $16.6 — | $5.57B — | 184.44 | $0.09 — | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Axsome Therapeutics, Inc. 19X.F | $95.86 104.79 USD |
+2.46
|
$4.93B 5.39B USD | $17 18.58 USD | $95.86 104.79 USD | $95.86 104.79 USD | $4.93B 5.39B USD | 0 | -$4.92 -5.3 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||